1-10 of 10
Jonathan Cebon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing

Free
Megan B. Barnet, Katherine J. Jackson, Bo Gao, Adnan M. Nagrial, Michael J. Boyer, Wendy A. Cooper, Rina Hui, Anthony Linton, Martin H. Tattersall, Greg Gibson, Jonathan Cebon, Georgina V. Long, Alexander M. Menzies, Richard A. Scolyer, Paul Lacaze, Robert Brink, Timothy Peters, Mark Cowley, Velimir Gayevskiy, David M. Thomas, Mark Pinese, Prunella Blinman, Steven Kao, Christopher C. Goodnow
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-121.
https://doi.org/10.1158/1538-7445.AM2018-LB-121
Published: 01 July 2018
View articletitled, Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing
Journal Articles

Abstract CT099: A phase I study of intralesional Bacillus Calmette-Guerin (BCG) followed by ipilimumab therapy in patients with advanced metastatic melanoma

Free
Jessica Duarte, Katherine Woods, Andreas Behren, Jonathan Cebon
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT099.
https://doi.org/10.1158/1538-7445.AM2017-CT099
Published: 01 July 2017
View articletitled, Abstract CT099: A phase I study of intralesional Bacillus Calmette-Guerin (BCG) followed by ipilimumab therapy in patients with advanced metastatic melanoma
Journal Articles

Abstract 2015: Thrombospondin-1 is a targetable marker of invasive, mesenchymal- like melanoma cells

Free
Andreas Behren, Aparna Jayachandran, Matthew Anaka, Christopher Hudson, Jonathan Cebon
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2015.
https://doi.org/10.1158/1538-7445.AM2014-2015
Published: 01 October 2014
View articletitled, Abstract 2015: Thrombospondin-1 is a targetable marker of invasive, mesenchymal- like melanoma cells
Journal Articles

Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling

Available to Purchase
Neil C. Robson, Laura Hidalgo, Tristan McAlpine, Heng Wei, Víctor G. Martínez, Ana Entrena, Gustavo J. Melen, Andrew S. MacDonald, Alexander Phythian-Adams, Rosa Sacedón, Eugene Maraskovsky, Jonathan Cebon, Manuel Ramírez, Angeles Vicente, Alberto Varas
Journal: Cancer Research
Cancer Res (2014) 74 (18): 5019–5031.
https://doi.org/10.1158/0008-5472.CAN-13-2845
Published: 14 September 2014
View articletitled, Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling
Open the PDF for Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling in another window
Includes: Supplementary data
Journal Articles

A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design

Available to Purchase
Lisa M. Ebert, Yu Chih Liu, Craig S. Clements, Neil C. Robson, Heather M. Jackson, Jessica L. Markby, Nektaria Dimopoulos, Bee Shin Tan, Immanuel F. Luescher, Ian D. Davis, Jamie Rossjohn, Jonathan Cebon, Anthony W. Purcell, Weisan Chen
Journal: Cancer Research
Cancer Res (2009) 69 (3): 1046–1054.
https://doi.org/10.1158/0008-5472.CAN-08-2926
Published: 29 January 2009
View articletitled, A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design
Open the PDF for A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design in another window
Journal Articles

ECSA/DPPA2 is an immunogenic embryo-cancer antigen that is co-expressed with cancer-testis antigens in non-small-cell lung cancer.

Free
Thomas John, Otavia Caballero, Suzanne Svobodova, Judy Browning, Siddhartha Deb, Melinda Hsu, Ramon Chua, Craig Gedye, Ian Davis, Yao-Tseng Chen, Marilyn Monk, Jonathan Cebon
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5311.
Published: 01 May 2008
View articletitled, ECSA/DPPA2 is an immunogenic embryo-cancer antigen that is co-expressed with cancer-testis antigens in non-small-cell lung cancer.
Journal Articles

Cancer/testis antigens are immunological targets for melanoma stem-like cells

Free
Craig Gedye, Juliet Quirk, Judy Browning, Suzanne Svobodova, Thomas John, P. Dunbar, Denis Corbeil, Jonathan Cebon, Ian Davis
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 5414.
Published: 01 May 2008
View articletitled, Cancer/testis antigens are immunological targets for melanoma stem-like cells
Journal Articles

The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells

Available to Purchase
Lisa M. Ebert, Bee Shin Tan, Judy Browning, Suzanne Svobodova, Sarah E. Russell, Naomi Kirkpatrick, Craig Gedye, Denis Moss, Sweet Ping Ng, Duncan MacGregor, Ian D. Davis, Jonathan Cebon, Weisan Chen
Journal: Cancer Research
Cancer Res (2008) 68 (8): 3001–3009.
https://doi.org/10.1158/0008-5472.CAN-07-5664
Published: 15 April 2008
View articletitled, The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Open the PDF for The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Recombinant human Interleukin-21 (IL-21) is well tolerated and can mediate biological effects in patients with metastatic melanoma (MM): preliminary results of a phase 1 study

Free
Ian D. Davis, Grant McArthur, Jonathan Cebon, Klaus S. Frederiksen, Dorthe Lundsgaard, Kresten Skak, Birte K. Skrumsager
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 677.
Published: 15 April 2006
View articletitled, Recombinant human Interleukin-21 (IL-21) is well tolerated and can mediate biological effects in patients with metastatic melanoma (MM): preliminary results of a phase 1 study
Journal Articles

Prognostic genetic alterations identified by microarray analysis in Stage III melanoma

Free
Tom John, Tumi Toro, Jonathan Cebon, Parry Guilford, Mik Black
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 200.
Published: 15 April 2006
View articletitled, Prognostic genetic alterations identified by microarray analysis in Stage III melanoma